Biocon Shares Rise Over 3% After Q2 Profit Turns Positive

New Delhi, November 13, 2025: Shares of Biocon Limited gained 3.28% on Thursday after the biotechnology company reported a strong turnaround in its Q2 earnings and announced a fund-raising plan. The stock opened at ₹407.15 and closed at ₹419.30, up from its previous close of ₹405.90. Throughout the trading session, Biocon maintained steady upward momentum, reaching an intraday high of ₹423.10, surpassing its 52-week high of ₹408.80. The company’s market capitalisation stood at ₹54,267.40 crore, with a P/E ratio of 111.80, reflecting renewed investor confidence following its improved performance.

Q2 FY26 Performance

The company delivered strong earnings in the second quarter of FY26, with profit recovery and a 20% expansion in revenue. Biocon reported a consolidated net profit of ₹85 crore for the July–September quarter, a significant turnaround from a net loss of ₹16 crore in the same period last year. Revenue from operations rose to ₹4,296 crore, up from ₹3,590 crore a year ago, marking a 20% year-on-year growth. According to Chairperson Kiran Mazumdar-Shaw, the quarter reflected robust growth led by the biosimilars segment, supported by improved traction in generics and steady performance from the CRDMO business, underscoring Biocon’s balanced growth momentum across its key verticals.

Board Approves Fundraising of ₹550 Crore

The company’s board has approved raising funds up to ₹550 crore through the issue of commercial papers through private placement in one or more tranches. The company indicated that it will enhance liquidity to support operational requirements and enhance financial flexibility. According to Kiran Mazumdar-Shaw, the resolution of structured debt obligations will help strengthen the balance sheet, improve financial flexibility, and enhance profitability.

REF: https://nsearchives.nseindia.com/corporate/Biocon2_11112025204534_Covering_Letter_Press_Release.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations